The global pancreatic cancer precision medicine market was valued at USD 551.01 million in 2023 and is projected to reach USD 2676.98 Million by 2032, expanding at a CAGR of 19.2% from 2024 to 2032. The growing demand for targeted therapies, immunotherapies, and biomarker-driven treatment strategies is significantly enhancing survival rates while minimizing treatment-related side effects. The increasing adoption of next-generation sequencing (NGS), molecular diagnostics, and liquid biopsy technologies is transforming pancreatic cancer detection and treatment by enabling personalized medicine approaches tailored to individual patient profiles.
The rising incidence of pancreatic cancer, driven by an aging population and lifestyle-related factors, is accelerating market demand. According to Cancer Australia, 4,641 new pancreatic cancer cases were diagnosed in 2024. The demand for innovative precision treatments is surging as pharmaceutical companies, biotech firms, and research institutions expand their efforts in clinical trials and drug discovery. Regulatory agencies such as the FDA and EMA have introduced fast-track approvals for precision medicine therapies, expediting the commercialization of novel treatments.
Among the therapeutic approaches, targeted therapy dominated the market in 2024, accounting for a 56.0% share. The rising adoption of monoclonal antibodies, PARP inhibitors, and KRAS/EGFR inhibitors has facilitated genetic mutation-based treatment selection. Meanwhile, immunotherapy, which includes immune checkpoint inhibitors (PD-1/PD-L1 inhibitors), cancer vaccines, and CAR-T therapies, is gaining traction due to its potential for long-term remission. Additionally, chemotherapy-precision combinations are projected to witness the fastest CAGR of 20.3% from 2025 to 2030, as they offer enhanced tumor-targeting capabilities through molecular profiling.
Regionally, North America led the market in 2024, with a revenue share of 42.9%, driven by advanced oncology research, robust healthcare infrastructure, and significant investments in genomic profiling. The U.S. pancreatic cancer precision medicine market accounted for 81.4% of the North American revenue share, benefiting from government research funding, increasing adoption of biomarker-based diagnostics, and strong regulatory support. Europe and Asia Pacific are also emerging as promising regions, with Asia Pacific expected to register the fastest CAGR of 6.1%, supported by growing cancer awareness, improving healthcare infrastructure, and rising clinical trial activity in countries such as Japan, China, and India.
Major Market Players Included in this Report:
• AstraZeneca
• Pfizer Inc.
• Novartis AG
• Amgen Inc.
• F. Hoffmann-La Roche Ltd
• Bayer AG
• Eli Lilly and Company
• Merck & Co., Inc.
• Teva Pharmaceutical Industries Ltd
• PharmaCyte Biotech, Inc.
• Genentech, Inc.
• Guardant Health
• Illumina, Inc.
• Thermo Fisher Scientific Inc.
• FOUNDATION MEDICINE, INC.
The Detailed Segments and Sub-Segments of the Market Are Explained Below:
By Therapeutic Approach:
• Targeted Therapy
PARP Inhibitors
Monoclonal Antibodies
Small Molecule Inhibitors (EGFR Inhibitors, KRAS Inhibitors)
• Immunotherapy
Immune Checkpoint Inhibitors (PD-1 Inhibitors, PD-L1 Inhibitors)
Cancer Vaccines (GVAX, Algenpantucel-L)
Adoptive T-Cell Therapies (CAR-T Therapies)
• Chemotherapy-Precision Combinations
• Other Therapeutic Approaches
By Diagnostic Technology:
• Genomic Testing
• Molecular Diagnostics
• Liquid Biopsy
• Biomarker-based Companion Diagnostics
• Others (Immunohistochemistry (IHC), Proteomics, Mass Spectrometry)
By Region:
North America
• U.S.
• Canada
• Mexico
Europe
• UK
• Germany
• France
• Italy
• Spain
• Denmark
• Sweden
• Norway
Asia Pacific
• Japan
• China
• India
• Australia
• South Korea
• Thailand
Latin America
• Brazil
• Argentina
Middle East & Africa
• South Africa
• Saudi Arabia
• UAE
• Kuwait
Years Considered for the Study:
• Historical year – 2022
• Base year – 2023
• Forecast period – 2024 to 2032
Key Takeaways:
• Market Estimates & Forecast for 10 years from 2022 to 2032.
• Annualized revenues and regional-level analysis for each market segment.
• Detailed analysis of the geographical landscape with country-level insights.
• Competitive landscape featuring major players in the market.
• Analysis of key business strategies and recommendations for future market expansion.
• Demand-side and supply-side analysis of the market.
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.
- Chapter 1. Global Pediatric Palliative Care Market Executive Summary
- 1.1. Global Pediatric Palliative Care Market Size & Forecast (2022 - 2032)
- 1.2. Regional Summary
- 1.3. Segmental Summary
- 1.3.1. By Disease Condition
- 1.3.2. By Provider
- 1.4. Key Market Trends
- 1.5. Recession Impact
- 1.6. Analyst Recommendation & Conclusion
- Chapter 2. Global Pediatric Palliative Care Market Definition and Research Assumptions
- 2.1. Research Objective
- 2.2. Market Definition
- 2.3. Research Assumptions
- 2.3.1. Inclusion & Exclusion
- 2.3.2. Limitations
- 2.3.3. Supply Side Analysis
- 2.3.3.1. Availability
- 2.3.3.2. Infrastructure
- 2.3.3.3. Regulatory Environment
- 2.3.3.4. Market Competition
- 2.3.3.5. Economic Viability (Consumer’s Perspective)
- 2.3.4. Demand Side Analysis
- 2.3.4.1. Regulatory Frameworks
- 2.3.4.2. Technological Advancements
- 2.3.4.3. Environmental Considerations
- 2.3.4.4. Consumer Awareness & Acceptance
- 2.4. Estimation Methodology
- 2.5. Years Considered for the Study
- 2.6. Currency Conversion Rates
- Chapter 3. Global Pediatric Palliative Care Market Dynamics
- 3.1. Market Drivers
- 3.1.1. Growing Prevalence of Pediatric Chronic Diseases
- 3.1.2. Advancements in Telehealth and Home-Based Care
- 3.1.3. Government Initiatives and Increased Funding for Pediatric Palliative Care
- 3.2. Market Challenges
- 3.2.1. Limited Access to Specialized Pediatric Palliative Care
- 3.2.2. High Cost of Treatment and Lack of Insurance Coverage
- 3.3. Market Opportunities
- 3.3.1. Expansion of Pediatric Palliative Care Services in Emerging Markets
- 3.3.2. Integration of AI and Digital Health Technologies
- 3.3.3. Strategic Collaborations and Mergers Among Healthcare Providers
- Chapter 4. Global Pediatric Palliative Care Market Industry Analysis
- 4.1. Porter’s Five Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.1.6. Futuristic Approach to Porter’s Five Force Model
- 4.1.7. Porter’s Five Force Impact Analysis
- 4.2. PESTEL Analysis
- 4.2.1. Political
- 4.2.2. Economic
- 4.2.3. Social
- 4.2.4. Technological
- 4.2.5. Environmental
- 4.2.6. Legal
- 4.3. Top Investment Opportunities
- 4.4. Top Winning Strategies
- 4.5. Disruptive Trends in Pediatric Palliative Care
- 4.6. Industry Expert Perspective
- 4.7. Analyst Recommendation & Conclusion
- Chapter 5. Global Pediatric Palliative Care Market Size & Forecasts by Disease Condition (2022 - 2032)
- 5.1. Segment Dashboard
- 5.2. Global Pediatric Palliative Care Market: Disease Condition Revenue Trend Analysis, 2022 & 2032 (USD Billion)
- 5.2.1. HIV
- 5.2.2. Premature Birth and Trauma
- 5.2.3. Congenital Malformations
- 5.2.4. Injury, Poisoning, and External Causes
- 5.2.5. Others
- Chapter 6. Global Pediatric Palliative Care Market Size & Forecasts by Provider (2022 - 2032)
- 6.1. Segment Dashboard
- 6.2. Global Pediatric Palliative Care Market: Provider Revenue Trend Analysis, 2022 & 2032 (USD Billion)
- 6.2.1. Hospitals & Clinics
- 6.2.2. Home-Based
- 6.2.3. Community Settings
- Chapter 7. Global Pediatric Palliative Care Market Size & Forecasts by Region (2022 - 2032)
- 7.1. North America Pediatric Palliative Care Market
- 7.1.1. U.S. Pediatric Palliative Care Market
- 7.1.1.1. Disease Condition Breakdown Size & Forecasts, 2022 - 2032
- 7.1.1.2. Provider Breakdown Size & Forecasts, 2022 - 2032
- 7.1.2. Canada Pediatric Palliative Care Market
- 7.1.3. Mexico Pediatric Palliative Care Market
- 7.2. Europe Pediatric Palliative Care Market
- 7.2.1. UK Pediatric Palliative Care Market
- 7.2.2. Germany Pediatric Palliative Care Market
- 7.2.3. France Pediatric Palliative Care Market
- 7.2.4. Italy Pediatric Palliative Care Market
- 7.2.5. Spain Pediatric Palliative Care Market
- 7.2.6. Rest of Europe Pediatric Palliative Care Market
- 7.3. Asia-Pacific Pediatric Palliative Care Market
- 7.3.1. China Pediatric Palliative Care Market
- 7.3.2. India Pediatric Palliative Care Market
- 7.3.3. Japan Pediatric Palliative Care Market
- 7.3.4. Australia Pediatric Palliative Care Market
- 7.3.5. South Korea Pediatric Palliative Care Market
- 7.3.6. Rest of Asia-Pacific Pediatric Palliative Care Market
- 7.4. Latin America Pediatric Palliative Care Market
- 7.4.1. Brazil Pediatric Palliative Care Market
- 7.4.2. Argentina Pediatric Palliative Care Market
- 7.4.3. Rest of Latin America Pediatric Palliative Care Market
- 7.5. Middle East & Africa Pediatric Palliative Care Market
- 7.5.1. Saudi Arabia Pediatric Palliative Care Market
- 7.5.2. South Africa Pediatric Palliative Care Market
- 7.5.3. Rest of Middle East & Africa Pediatric Palliative Care Market
- Chapter 8. Competitive Intelligence
- 8.1. Key Company SWOT Analysis
- 8.1.1. Adventist Health
- 8.1.2. Boston Children’s Hospital
- 8.1.3. Children’s Hospital Los Angeles
- 8.2. Top Market Strategies
- 8.3. Company Profiles
- Chapter 9. Research Process
- 9.1. Research Methodology
- 9.1.1. Data Collection
- 9.1.2. Primary Research
- 9.1.3. Secondary Research
- 9.1.4. Data Triangulation
- 9.1.5. Market Breakdown & Data Validation
- 9.1.6. Assumptions & Limitations
- 9.2. Research Attributes
- 9.2.1. Definition of Market Segments
- 9.2.2. Key Market Indicators
- 9.2.3. Forecasting Techniques & Data Modeling
- 9.2.4. Competitive Landscape Analysis Approach
- 9.2.5. Economic & Market Impact Assessment
- 9.3. Data Sources
- 9.3.1. Public Databases & Industry Reports
- 9.3.2. Government & Regulatory Authorities
- 9.3.3. Company Annual Reports & SEC Filings
- 9.3.4. Expert Interviews & Industry Insights
- 9.4. Market Estimation Techniques
- 9.4.1. Top-Down Approach
- 9.4.2. Bottom-Up Approach
- 9.4.3. Demand-Supply Gap Analysis
- 9.4.4. Market Penetration Analysis
- 9.5. Data Validation & Cross-Verification
- 9.5.1. Internal Data Validation
- 9.5.2. External Market Validation from Key Industry Experts
- 9.6. Study Scope & Customization Options
- 9.6.1. Customization Scope Based on Geography
- 9.6.2. Additional Customization for Market Segments
- 9.6.3. Post-Purchase Support & Data Updates
- List of Tables
- TABLE 1. Global Pediatric Palliative Care Market, Report Scope
- TABLE 2. Global Pediatric Palliative Care Market Estimates & Forecasts by Region, 2022-2032 (USD Billion)
- TABLE 3. Global Pediatric Palliative Care Market Estimates & Forecasts by Disease Condition, 2024-2032 (USD Billion)
- TABLE 4. Global Pediatric Palliative Care Market Estimates & Forecasts by Provider, 2022-2032 (USD Billion)
- TABLE 5. North America Pediatric Palliative Care Market by Country, 2022-2032 (USD Billion)
- TABLE 6. Europe Pediatric Palliative Care Market by Country, 2022-2032 (USD Billion)
- TABLE 7. Asia Pacific Pediatric Palliative Care Market by Country, 2022-2032 (USD Billion)
- TABLE 8. Latin America Pediatric Palliative Care Market by Country, 2022-2032 (USD Billion)
- TABLE 9. Middle East & Africa Pediatric Palliative Care Market by Country, 2022-2032 (USD Billion)
- TABLE 10. U.S. Pediatric Palliative Care Market Breakdown by Disease Condition, 2022-2032 (USD Billion)
- TABLE 11. Canada Pediatric Palliative Care Market Breakdown by Provider, 2022-2032 (USD Billion)
- TABLE 12. Germany Pediatric Palliative Care Market Breakdown by Disease Condition, 2022-2032 (USD Billion)
- TABLE 13. China Pediatric Palliative Care Market Breakdown by Provider, 2022-2032 (USD Billion)
- TABLE 14. Japan Pediatric Palliative Care Market Breakdown by Provider, 2022-2032 (USD Billion)
- TABLE 15. Competitive Landscape: Key Players & Market Share, 2023 (%)
- TABLE 16. Company Financial Performance, Revenue Analysis 2023-2032 (USD Billion)
- TABLE 17. Major Partnerships & Collaborations in the Pediatric Palliative Care Market (2022-2032)
- TABLE 18. Pediatric Palliative Care Market: Government Initiatives & Funding Programs, 2022-2032
- TABLE 19. R&D Spending in the Pediatric Palliative Care Market (2022-2032)
- TABLE 20. Innovations & New Product Launches in the Pediatric Palliative Care Market, 2022-2032
- This list is not complete; the final report contains more than 100 tables. The list may be updated in the final deliverable.
- List of Figures
- FIGURE 1. Global Pediatric Palliative Care Market, Research Methodology
- FIGURE 2. Global Pediatric Palliative Care Market, Market Estimation Techniques
- FIGURE 3. Global Pediatric Palliative Care Market Size Estimates & Forecasts, 2022-2032 (USD Billion)
- FIGURE 4. Global Pediatric Palliative Care Market Key Trends, 2023
- FIGURE 5. Porter’s Five Forces Analysis for the Global Pediatric Palliative Care Market
- FIGURE 6. PESTEL Analysis of the Pediatric Palliative Care Market
- FIGURE 7. Value Chain Analysis of the Pediatric Palliative Care Market
- FIGURE 8. Pediatric Palliative Care Market by Disease Condition, 2022 & 2032 (USD Billion)
- FIGURE 9. Pediatric Palliative Care Market by Provider, 2024 & 2032 (USD Billion)
- FIGURE 10. Regional Snapshot of the Pediatric Palliative Care Market, 2022 & 2032 (USD Billion)
- FIGURE 11. North America Pediatric Palliative Care Market, 2022 & 2032 (USD Billion)
- FIGURE 12. Europe Pediatric Palliative Care Market, 2022 & 2032 (USD Billion)
- FIGURE 13. Asia Pacific Pediatric Palliative Care Market, 2022 & 2032 (USD Billion)
- FIGURE 14. Market Share Analysis of Key Players in the Pediatric Palliative Care Market, 2023 (%)
- FIGURE 15. R&D Spending in the Pediatric Palliative Care Market (2018-2024) (USD Billion)
- FIGURE 16. Mergers and Acquisitions in the Pediatric Palliative Care Market (2022-2032)
- FIGURE 17. Government Investments in Pediatric Palliative Care Infrastructure, 2022-2032
- FIGURE 18. Pediatric Palliative Care Market: Adoption Rate of Telehealth Services, 2022-2032
- FIGURE 19. Number of Pediatric Palliative Care Facilities Worldwide, 2022-2032
- FIGURE 20. Growth in Awareness & Training Programs for Pediatric Palliative Care, 2022-2032
- This list is not complete; the final report contains more than 50 figures. The list may be updated in the final deliverable.
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook